Primary sclerosing cholangitis patient 21003LF, baseline, effector T cell, low-dose IL-2 trial
RNA-seq library from purified effector T cells isolated from peripheral blood of patient 21003LF enrolled in the TRANSREG trial (NCT01988506) and treated with low-dose IL-2. Sample collected at baseline. Disease: Primary sclerosing cholangitis. Clinical response status: Non-responder.
isolate
TRANSREG_21003LF_BL_Teff
age
44.4
biomaterial_provider
Sorbonne Universit, Inserm, UMRS 959, Paris, France
collection_date
missing
geo_loc_name
France: Paris
sex
female
tissue
peripheral blood
cell_subtype
effector T cell
cell_type
CD4-positive T cell
disease
Primary sclerosing cholangitis
race
not collected
sample_type
isolated cells
treatment
low-dose IL-2; time point baseline
BioSampleModel
Human